TONIX PHARMACEUTICALS

Lobbying client · New Jersey · filed 2025 to 2026

Biopharmaceutical

$750,000 Reported spend

33 Filings counted

6 Outside firms hired

0 Bills named

Spend is reported income plus in-house expenses across 33 filings. 2 further filings for this client were restated by a later amendment and are left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 6 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as TONIX PHARMACEUTICALS, INC.

Who filed for this client 6

VALCOUR LLC $210,000 Outside firm · 7 filings
FOLEY HOAG LLP $190,000 Outside firm · 8 filings
BROYDRICK & ASSOCIATES $140,000 Outside firm · 7 filings
STRATEGIC MARKETING INNOVATIONS $130,000 Outside firm · 5 filings
CARDINAL POINT PARTNERS $60,000 Outside firm · 4 filings
POLSINELLI PC $20,000 Outside firm · 2 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Reported by year 2 years

2026 $400,000 14 filings
2025 $350,000 19 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

HOUSE OF REPRESENTATIVES 26
SENATE 26
Defense, Dept of (DOD) 7
Health & Human Services, Dept of (HHS) 5

Recent filings 35 total

Q3 report

VALCOUR LLC

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 20, 2026

View → Q3 report

STRATEGIC MARKETING INNOVATIONS

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 18, 2026

View → Q3 report

BROYDRICK & ASSOCIATES

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 15, 2026

View → Q3 report

POLSINELLI PC

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 8, 2026

View → Registration

POLSINELLI PC

3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 6, 2026

View → Q3 termination

FOLEY HOAG LLP

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Aug 7, 2026

View → Q2 report

VALCOUR LLC

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Jul 20, 2026

View → Q2 report

BROYDRICK & ASSOCIATES

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Jul 18, 2026

View → Q2 report

BROYDRICK & ASSOCIATES Amended

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Jul 18, 2026

View → Q2 report

STRATEGIC MARKETING INNOVATIONS

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 17, 2026

View → Q2 report

FOLEY HOAG LLP

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 17, 2026

View → Q4 terminationNo activity

CARDINAL POINT PARTNERS

4th Quarter 2025 (Oct 1 - Dec 31) · posted Jul 1, 2026

View → Q3 reportNo activity

CARDINAL POINT PARTNERS

3rd Quarter 2025 (July 1 - Sep 30) · $20,000 income · posted Jul 1, 2026

View → Q1 report

VALCOUR LLC

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $30,000 income · posted Apr 20, 2026

View → Q1 report

BROYDRICK & ASSOCIATES

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $20,000 income · posted Apr 19, 2026

View → Q1 report

FOLEY HOAG LLP

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 17, 2026

View → Q1 report

STRATEGIC MARKETING INNOVATIONS

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 16, 2026

View → Q4 report

STRATEGIC MARKETING INNOVATIONS

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $10,000 income · posted Jan 21, 2026

View → Q4 report

VALCOUR LLC

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $30,000 income · posted Jan 20, 2026

View → Q4 report

FOLEY HOAG LLP

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $20,000 income · posted Jan 19, 2026

View →

Showing the 20 most recent of 35 filings. Search the explorer for "TONIX PHARMACEUTICALS".

Keep going

Filings through October 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.